Friday, Sep 17, 2021
Bermuda News Online
Add Your News
Russia wants to win the race for the coronavirus vaccine
Moscow researchers say one of the country's possible coronavirus vaccines has proven safe in small-scale human trials and is ready for further testing.
UK secures 90 million doses of Covid-19 vaccine
The British government announced on Monday the signing of two agreements for the purchase of a total of 90 million doses of two vaccines against Covid-19 under development.
Moderna, Pfizer & Merck: coronavirus vaccines will not be sold at cost price
US labs Pfizer, Merck and Moderna said Tuesday that if they get the new coronavirus vaccine, they will not sell it at cost, during a hearing in the United States Congress.
Don't hold your breath for a coronavirus vaccine. Here are the 7 biggest challenges we still need to overcome.
Drugmakers, scientists, and governments are racing to develop a coronavirus vaccine at unprecedented speeds.. It seems possible, or even likely, that a vaccine could be available by early 2021.. But there are countless obstacles to creat...
More than 5 billion doses of Covid-19 vaccines have already been purchased globally
Although no experimental vaccine has yet demonstrated efficacy against the new coronavirus in clinical trials, at least 5.7 billion doses have already been purchased in advance worldwide, and the first orders have been advanced by the Un...
President of Mexico says he is willing to get Russia's vaccine against Covid-19
The president of Mexico, Andrés Manuel López Obrador, said on Monday that he would be willing to apply Russia's vaccine against the coronavirus if it was effective.
Johnson & Johnson begins the last stage of clinical trials of its COVID-19 vaccine
Johnson & Johnson became the fourth pharmaceutical group to begin phase 3 clinical trials of its experimental vaccine against Covid-19 in the United States on Wednesday.
UK’s chief scientific adviser has £600,000 of shares in vaccine maker contracted by govt – reports
UK Chief Scientific Adviser Sir Patrick Vallance reportedly holds a bonus of tens of thousands of shares in a pharma giant developing a Covid-19 vaccine for the government. Yet, London says there is no conflict of interest.
Novavax Covid-19 vaccine begins final phase of clinical trial
The American biotechnology company Novavax announced on Thursday, September 24, that it began in the United Kingdom a final phase clinical trial for its experimental vaccine against Covid-19, the eleventh vaccine in the world to reach th...
Pharmaceutical companies to have vaccine in the U.S. by the end of the year
October is a crucial month in the race for a Covid-19 vaccine, with advances that could lead to some Americans getting vaccinated by the end of 2020.
Time to Reset Expectations for World Economy With Virus Untamed
Investors banking on a coronavirus vaccine to save the world economy in 2021 need to temper their ambitions as scientists increasingly warn of a long and difficult road ahead.
‘We’re not there yet’: British health minister dashes hopes AstraZeneca vaccine could be ready before Christmas
The British minister of health has rebuffed claims that a UK vaccine could be widely distributed in 2020, adding that his “central expectation” is for roll-out in the first half of 2021.
Pfizer’s and BioNTech’s vaccine is the start of the end of the pandemic
Its 90% effectiveness is as good as it gets, and bodes well for other vaccines. But getting them quickly to the right people will be hard
Why the Pfizer-BioNTech vaccine is no cure for all coronavirus ills
Amid the excitement over a vaccine said to be 90 per cent effective, questions remain over virus mutations, people refusing to take it and the problem of storing it at -80 degrees.
Britain to become first country to trial AstraZeneca coronavirus antibody treatment
New antibody combination aims to help people with weakened immune systems
AstraZeneca shares fall after efficacy findings for Covid-19 vaccine
Analysts say ‘lower efficacy for higher dose’ needs explaining, as results below those of rivals
Russia says its Sputnik V vaccine against Covid-19 is 95% effective
Russia said Tuesday that its Sputnik V vaccine against Covid-19, developed by the Gamaleya research center in Moscow, is 95% effective.
After Admitting Mistake, AstraZeneca Faces Difficult Questions About Its Vaccine
Some trial participants only got a partial dose of AstraZeneca’s vaccine. Experts said the company’s spotty disclosures have eroded confidence.
Oxford/AstraZeneca vaccine results face growing scrutiny
Share price drops as critics question claim vaccine could protect up to 90% of people
AstraZeneca and Oxford defend Covid vaccine trials after questions raised in the U.S.
“We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.
Fake News, Misinformation Threaten Covid-19 Vaccination Plan: WHO
"The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected," the WHO said.
Oxford, WHO scientists say more data needed on AstraZeneca's Covid vaccine trials
More data is needed from AstraZeneca's Covid vaccine trials beyond what was presented in a press release, experts from the WHO and Oxford University said.
NHS to enlist 'sensible' celebrities to persuade people to take coronavirus vaccine
Exclusive: People who are ‘known and loved’ will front campaign amid fears of low take-up
US Expects To Vaccinate 100 Million People Against Covid By February
The push should start within weeks, when vaccines developed by Pfizer-BioNTech and Moderna-NIH are expected to be approved.
Add Your News